Polymer based solutions of bupranolol hydrochloride for intranasal systemic delivery

References

• Ahuja A, Khar RK, Ali J. (1997). Mucoadhesive drug delivery system. Drug Dev Ind Pharm, 23, 489–515.
   Web of Science ®Google Scholar
• Aikawa K, Mitsutake N, Uda H, Tanaka S, Shimamura H, Aramaki Y, Tsuchiya S. (1998). Drug release from pH-response polyvinylacetal diethylaminoacetate hydrogel and application to nasal delivery. Int J Pharm 168, 181–188.
   Google Scholar
• Aspden TJ, Illum L, Skaugrud O. (1996). Chitosan as a nasal delivery system: Evaluation of insulin absorption enhancement and effect on nasal membrane integrity using rat models. Eur J Pharm Sci, 4, 23–31.
   Web of Science ®Google Scholar
• Aspden TJ, Mason JD, Jones NS, Lowe J, Skaugrud O, Illum L. (1997). Chitosan as a nasal delivery system: the effect of chitosan solutions on in vitro and in vivo mucociliary transport rates in human turbinates and volunteers. J Pharm Sci, 86, 509–513.
   PubMed Web of Science ®Google Scholar
• Behl CR, Pimplaskar HK, Sileno AP, deMeireles J, Romeo VD. (1998). Effects of physicochemical properties and other factors on systemic nasal drug delivery. Adv Drug Deliv Rev, 29, 89–116.
   PubMed Web of Science ®Google Scholar
• Chelladurai S, Mishra M, Mishra B. (2008). Design and evaluation of bioadhesive in-situ nasal gel of ketorolac tromethamine. Chem Pharm Bull, 56, 1596–1599.
   PubMed Web of Science ®Google Scholar
• Chu JS, Chandrasekharan R, Amidon GL, Weiner ND, Goldberg AH. (1991). Viscometric study of polyacrylic acid systems as mucoadhesive sustained-release gels. Pharm Res, 8, 1408–1412.
   PubMed Web of Science ®Google Scholar
• Cordes G, Fischer W, Legler U, Wolff HM. (1988). Development of a novel transedermal therapeutic system for bupranolol. Ther Res, 8, 139–153.
   Google Scholar
• Harris AS, Ohlin M, Lethagen S, Nilsson IM. (1988). Effects of concentration and volume on nasal bioavailability and biological response to desmopressin. J Pharm Sci, 77, 337–339.
   PubMed Web of Science ®Google Scholar
• Higuchi WI. (1962).The analysis of data on the medicament release from ointments. J Pharm Sci, 51, 802–804.
   PubMed Web of Science ®Google Scholar
• Johnson P, Rainsford KD. (1972). The physical properties of mucus: preliminary observations on the sedimentation behaviour of porcine gastric mucus. Biochim Biophys Acta, 286, 72–78.
   PubMed Web of Science ®Google Scholar
• Junginger HE. (1991). Mucoadhesive hydrogels. Pharm Ind, 53, 1056–1065.
   Web of Science ®Google Scholar
• Kissel T, Drewe J, Bantle S, Rummelt A, Beglinger C. (1992). Tolerability and absorption enhancement of intranasally administered octreotide by sodium taurodihydrofusidate in healthy subjects. Pharm Res, 9, 52–57.
   PubMed Web of Science ®Google Scholar
• Lorenzo-Lamosa ML, Remuñán-López C, Vila-Jato JL, Alonso MJ. (1998). Design of microencapsulated chitosan microspheres for colonic drug delivery. J Control Release, 52, 109–118.
   PubMed Web of Science ®Google Scholar
• Madsen F, Eberth K, Smart JD. (1998). A rheological examination of the mucoadhesive/mucus interaction: the effect of mucoadhesive type and concentration. J Control Release, 50, 167–178.
   PubMed Web of Science ®Google Scholar
• Mishra B, Panayam J, Sharma AV. (1999). Mechanisms of drug release control by osmotic additives from multiple w/o/w emulsions containing diclofenac sodium. Acta Pharm Turc, 41, 58–61.
   Google Scholar
• Morimoto K, Tabata H, Morisaka K. (1987). Nasal absorption of nifedipine from gel preparations in rats. Chem Pharm Bull, 35, 3041–3044.
   PubMed Web of Science ®Google Scholar
• Morimoto K, Morisaka K, Kamada A. (1985). Enhancement of nasal absorption of insulin and calcitonin using polyacrylic acid gel. J Pharm Pharmacol, 37, 134–136.
   PubMed Web of Science ®Google Scholar
• Nakamura F, Ohta R, Machida Y, Nagai T. (1996).In vitro and in vivo nasal mucoadhesion of some water soluble polymers. Int J Pharm, 134, 173–181.
   Web of Science ®Google Scholar
• Park H, Amiji M, Park K. (1989). Mucoadhesive hydrogel effective at neutral pH. Proc Int Sym Control Rel Bioact Mater, 16, 217–218.
   Google Scholar
• Pennington AK, Ratcliffe JH, Wilson CG, Hardy JG. (1988). The Influence of solution viscosity on nasal spray deposition and clearance. Int J Pharm, 43, 221–224.
   Web of Science ®Google Scholar
• Peppas NA. (1985). Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv, 60, 110–111.
   PubMedGoogle Scholar
• Rajinikanth PS, Sankar C, Mishra B. (2003). Sodium alginate microspheres of metoprolol tartrate for intranasal systemic delivery: development and evaluation. Drug Deliv, 10, 21–28.
   PubMed Web of Science ®Google Scholar
• Remigius UA, Jorissen M, Willems T, Kinget R, Verbeke N. (2003). Mechanistic appraisal of the effects of some protease inhibitors on ciliary beat frequency in a sequential cell culture system of human nasal epithelium. Eur J Pharm Biopharm, 55, 283–289.
   PubMed Web of Science ®Google Scholar
• Reynolds, JEF. (Ed.), Bupranolol Hydrochloride. Martindale, The Extra Pharmcopoeia, The Pharmaceutical Press, London, 1993, pp.631.
   Google Scholar
• Sankar C, Mishra B. (2003). Development and in vitro evaluations of gelatin A microspheres of ketorolac tromethamine for intranasal administration. Acta Pharm, 53, 101–110.
   PubMedGoogle Scholar
• Sankar C, Rani M, Srivastava AK, Mishra B. (2001a). Chitosan based pentazocine microspheres for intranasal systemic delivery: development and biopharmaceutical evaluation. Pharmazie, 56, 223–226.
   PubMed Web of Science ®Google Scholar
• Sankar C, Srivastava AK, Mishra B. (2001b). Cross-linked chitosan microspheres of pentazocine for intranasal administration, Acta Pharm Turc, 42, 11–15.
   Google Scholar
• Shin SC, Cho CW, Choi HK, Oh IJ. (2000). Enhanced efficacy by percutaneous absorption of piroxicam from the poloxamer gel in rats. Int J Pharm, 193, 213–218.
   PubMed Web of Science ®Google Scholar
• Smith J, Wood E, Dornish M. (2004). Effect of chitosan on epithelial cell tight junctions. Pharm Res, 21, 43–49.
   PubMed Web of Science ®Google Scholar
• Tur K.M, Ch’ng HS. (1998). Evaluation of possible mechanism of bioadhesion. Int J Pharm. 160, 61–74.
   Google Scholar
• Washington N, Steele RJ, Jackson SJ, Bush D, Mason J, Gill DA, Pitt K, Rawlins DA. (2000). Determination of baseline human nasal pH and the effect of intranasally administered buffers. Int J Pharm, 198, 139–146.
   PubMed Web of Science ®Google Scholar
• Wellstein A, Küppers H, Pitschner HF, Palm D. (1986). Transdermal delivery of bupranolol: pharmacodynamics and beta-adrenoceptor occupancy. Eur J Clin Pharmacol, 31, 419–422.
   PubMed Web of Science ®Google Scholar